FOUR-YEAR OUTCOME OF 215 NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH NILOTINIB FRONTLINE: A GIMEMA CML WORKING PARTY ANALYSIS

被引：0

作者：

Gugliotta, G. ^{[1
]}

Castagnetti, F. ^{[1
]}

Breccia, M. ^{[2
]}

Levato, L. ^{[3
]}

Fava, C. ^{[4
]}

Luciano, L. ^{[5
]}

Zaccaria, A. ^{[6
]}

Rossi, A. Russo ^{[7
]}

Usala, E. ^{[8
,9
]}

Gozzini, A. ^{[10
]}

Vigneri, P. ^{[11
]}

Cedrone, M. ^{[12
]}

Tiribelli, M. ^{[13
,14
]}

Abruzzese, E. ^{[15
]}

Avanzini, P. ^{[16
]}

Palandri, F. ^{[1
]}

Soverini, S. ^{[1
]}

Alimena, G. ^{[2
]}

Pane, F. ^{[5
]}

Martinelli, G. ^{[1
]}

Cavo, M. ^{[1
]}

Saglio, G. ^{[4
]}

Baccarani, M. ^{[17
]}

Rosti, G. ^{[1
]}

机构：

[1] Univ Bologna, S Orsola Malpighi Hosp, Dept Expt Diagnost & Specialty Med, Bologna, Italy

[2] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, I-00185 Rome, Italy

[3] Azienda Osped Pugliese Ciaccio, Dept Hematol, Catanzaro, Italy

[4] Univ Turin, San Luigi Gonzaga Hosp, Div Internal Med Hematol, Turin, Italy

[5] Univ Naples Federico II, Dept Hematol CEINGE & Adv Biotechonolgies, Naples, Italy

[6] IRST IRCCS, Hematol Unit, Meldola, Forli Cesena, Italy

[7] Univ Bari, Dept Emergency & Organ Transplantat, Hematol Unit, Bari, Italy

[8] Armando Businco Hosp, Cagliari, Italy

[9] Armando Businco Hosp, Bone Marrow Transplantat Unit, Cagliari, Italy

[10] Univ Florence, Careggi Hosp, Dept Hematol, Florence, Italy

[11] Univ Catania, Ferrarotto Hosp, Div Hematol, Catania, Italy

[12] San Giovanni Hosp, Hematol Unit, Rome, Italy

[13] Univ Udine, Dept Expt & Clin Med Sci, Div Hematol, I-33100 Udine, Italy

[14] Univ Udine, Dept Expt & Clin Med Sci, I-33100 Udine, Italy

[15] S Eugenio Hosp, Dept Hematol, Rome, Italy

[16] Santa Maria Nuova Hosp, Hematol Unit, Reggio Emilia, Italy

[17] Univ Bologna, Bologna, Italy

来源：

HAEMATOLOGICA | 2014年 / 99卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P892

引用

页码：333 / 333

页数：1

共 50 条

[41] Efficacy and safety of nilotinib therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase
Michihide Tokuhira
Yuta Kimura
Keiji Sugimoto
Tomonori Nakazato
Maho Ishikawa
Isao Fujioka
Tomoiku Takaku
Noriyoshi Iriyama
Eriko Sato
Hiroyuki Fujita
Yoshihiro Hatta
Norio Komatsu
Norio Asou
Masahiro Kizaki
Tatsuya Kawaguchi
Medical Oncology, 2018, 35
[42] Gimema Registry of Conception/Pregnancy in Adult Patients Diagnosed with Chronic Myeloid Leukemia (CML) Treated with Tyrosine Kinase Inhibitors (TKIs)
Abruzzese, Elisabetta
Scortechini, Anna Rita
Gugliotta, Gabriele
Pierri, Ivana
Musolino, Caterina
Iurlo, Alessandra
Mastrullo, Lucia
Caracciolo, Clementina
Orlandi, Ester
Galimberti, Sara
Salvucci, Marzia
Avanzini, Paolo
Sica, Simona
Alimena, Giuliana
Bocchia, Monica
Pregno, Patrizia
D'Emilio, Anna
Gambacorti-Passerini, Carlo
Stagno, Fabio
Santorsola, Domenico
Castagnetti, Fausto
Perrotti, Alessio Pio
de Fabritiis, Paolo
Baccarani, Michele
BLOOD, 2014, 124 (21)
[43] Efficacy and safety of nilotinib therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase
Tokuhira, Michihide
Kimura, Yuta
Sugimoto, Keiji
Nakazato, Tomonori
Ishikawa, Maho
Fujioka, Isao
Takaku, Tomoiku
Iriyama, Noriyoshi
Sato, Eriko
Fujita, Hiroyuki
Hatta, Yoshihiro
Komatsu, Norio
Asou, Norio
Kizaki, Masahiro
Kawaguchi, Tatsuya
MEDICAL ONCOLOGY, 2018, 35 (03)
[44] Ten-Year Follow-up of Patients with Chronic Myeloid Leukemia Treated with Nilotinib in First-Line: Final Results of the Gimema CML 0307 Trial
Gugliotta, Gabriele
Castagnetti, Fausto
Breccia, Massimo
Levato, Luciano
Intermesoli, Tamara
D'adda, Mariella
Salvucci, Marzia
Stagno, Fabio
Cambrin, Giovanna Rege
Tiribelli, Mario
Martino, Bruno
Bocchia, Monica
Trabacchi, Elena
Cavazzini, Francesco
Porretto, Ferdinando
Sora, Federica
Caocci, Giovanni
Albano, Francesco
Martinelli, Giovanni
Soverini, Simona
Foa, Robin
Pane, Fabrizio
Cavo, Michele
Saglio, Giuseppe
Baccarani, Michele
Rosti, Gianantonio
BLOOD, 2019, 134
[45] Correction to: Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis
Hagop M. Kantarjian
Timothy P. Hughes
Richard A. Larson
Dong-Wook Kim
Surapol Issaragrisil
Philipp le Coutre
Gabriel Etienne
Carla Boquimpani
Ricardo Pasquini
Richard E. Clark
Viviane Dubruille
Ian W. Flinn
Slawomira Kyrcz-Krzemien
Ewa Medras
Maria Zanichelli
Israel Bendit
Silvia Cacciatore
Ksenia Titorenko
Paola Aimone
Giuseppe Saglio
Andreas Hochhaus
Leukemia, 2021, 35 : 2142 - 2143
[46] Chronic Myeloid Leukemia (CML) Patients with "Suboptimal" Response to Imatinib (IM) According to European LeukemiaNet Criteria Have a Poorer Outcome with Respect to "Optimal" Responders: A GIMEMA CML WORKING PARTY Analysis.
Castagnetti, Fausto
Gugliotta, Gabriele
Palandri, Francesca
Breccia, Massimo
Amabile, Marilina
Iacobucci, Ilaria
Testoni, Nicoletta
Marzocchi, Giulia
Luatti, Simona
Specchia, Giorgina
Intermesoli, Tamara
Abruzzese, Elisabetta
Capucci, Adele
Levato, Luciano
Radaelli, Franca
Martino, Bruno
Pregno, Patrizia
Montefusco, Enrico
Trentin, Livio
Alimena, Giuliana
Martinelli, Giovanni
Pane, Fabrizio
Saglio, Giuseppe
Baccarani, Michele
Rosti, Gianantonio
BLOOD, 2009, 114 (22) : 864 - 864
[47] Nilotinib versus imatinib in patients (pts) with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP): ENESTnd 4-year (y) update
Larson, Richard A.
Hochhaus, Andreas
Saglio, Giuseppe
Kim, Dong-Wook
Jootar, Saengsuree
Le Coutre, Philipp D.
Reiffers, Josy
Pasquini, Ricardo
Goldberg, Stuart L.
Clark, Richard E.
Kemp, Charisse N.
Fan, Xiaolin
Menssen, Hans D.
Hughes, Timothy P.
Kantarjian, Hagop M.
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[48] Old Age Affects Survival but Not Response in Philadelphia Positive (Ph+) Chronic Myeloid Leukemia (CML) Patients Treated with Imatinib (IM): A Study of the GIMEMA CML WORKING PARTY.
Gugliotta, Gabriele
Castagnetti, Fausto
Palandri, Francesca
Breccia, Massimo
Amabile, Marilina
Soverini, Simona
Testoni, Nicoletta
Marzocchi, Giulia
Baldazzi, Carmen
Annunziata, Mario
Usala, Emilio
Sica, Simona
Tiribelli, Mario
Bocchia, Monica
Gozzini, Antonella
Russo, Sabina
Palmieri, Fausto
Meneghini, Vittorio
D'Emilio, Anna
Alimena, Giuliana
Martinelli, Giovanni
Pane, Fabrizio
Saglio, Giuseppe
Baccarani, Michele
Rosti, Gianantonio
BLOOD, 2009, 114 (22) : 458 - 459
[49] Nilotinib as frontline therapy for patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase: results from the Japanese subgroup of ENESTnd
Hirohisa Nakamae
Hirohiko Shibayama
Mineo Kurokawa
Tetsuya Fukuda
Chiaki Nakaseko
Yoshinobu Kanda
Tadashi Nagai
Kazunori Ohnishi
Yasuhiro Maeda
Akira Matsuda
Taro Amagasaki
Masamitsu Yanada
International Journal of Hematology, 2011, 93 : 624 - 632
[50] Nilotinib as frontline therapy for patients with newly diagnosed Ph plus chronic myeloid leukemia in chronic phase: results from the Japanese subgroup of ENESTnd
Nakamae, Hirohisa
Shibayama, Hirohiko
Kurokawa, Mineo
Fukuda, Tetsuya
Nakaseko, Chiaki
Kanda, Yoshinobu
Nagai, Tadashi
Ohnishi, Kazunori
Maeda, Yasuhiro
Matsuda, Akira
Amagasaki, Taro
Yanada, Masamitsu
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (05) : 624 - 632

← 1 2 3 4 5 →